Plain-English translation of NCT06353542 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether artificial intelligence software can accurately identify glaucoma (an eye disease that damages the optic nerve) by analyzing eye photographs. Researchers want to see if AI can work as well as eye specialists at detecting glaucoma and whether it's cost-effective for screening in regular doctor's offices.
Glaucoma often goes undetected because it causes no early symptoms, and many people don't have regular access to eye specialists. This research could help catch glaucoma earlier in primary care settings by using AI to quickly analyze eye images, making screening easier and more affordable.
You likely qualify if…
You likely don't qualify if…
You'll have standard eye tests including vision checks and eye photographs. You'll then be randomly assigned to one of two groups: either have your eye photograph analyzed by AI software to determine if you have glaucoma, or be examined by an eye specialist. Either way, a second eye specialist will review your results without knowing which method was used, to compare how well both approaches work.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Spain
Hospital Clinic of Barcelona
Enrollment target
~500 participants
Started
May 2024
Primary completion
March 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
40 Years – 80 Years
Last updated on clinicaltrials.gov in October 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Nestor Ventura Abreu, MD, PhD
Glaucoma Consultant - Head of Ophthalmic Surgery Department
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.